When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
Most Popular Stories
- Thoroughbred Makeover is Bigger, Interactive
- Wise Dan Faces Stiff Shadwell Turf Mile Test
- Jacks or Better Loaded in Florida Sire Stakes
- How to Manage a Collapsed Foal
- Winners Named in TCA Youth Essay Contest
- Will Wise Dan Win Again in Shadwell Turf Mile
- Cup Winners Secret Circle, Goldencents Clash
- Wicked Strong to Sit Out Rest of Year
- Champagne Stakes is Next Step for I Spent It
- Wonder Gal Seeks Rebound in Frizette Stakes